NantHealth® Showcases DeviceConX™ Version 5.15 at Vitalis, Largest eHealth Event in Scandinavia
May 21 2019 - 11:15AM
Business Wire
New Enhancements Advance Medical Device
Interoperability and Clinician Productivity; Two Critical
Components for Reducing Errors and Streamlining Processes within
Health Care Networks
NantHealth, Inc. (NASDAQ: NH), a leader in connected care
solutions, showcases DeviceConX™ Version 5.15 at Vitalis, one of
the largest e-health events in Scandinavia. NantHealth’s Connected
Care solutions integrate medical device data into clinical records
which may lead to reduced length of stay, less costly medical
errors, greater provider satisfaction and improved outcomes.
An extremely flexible software-based platform designed for
complete connectivity and interoperability, DeviceConX facilitates
the capture of patient data from any capable medical device.
Leveraging a combination of existing hardware investments—including
bedside PCs, laptops, tablets, workstations-on-wheels, and
NantHealth’s HBox hardware—DeviceConX can then deliver that medical
device data to an EMR or any other clinical system quickly and
accurately.
The latest DeviceConX version 5.15 includes the ability to:
- Support high-resolution, high-fidelity
medical device data, including waveform capture
- Push over-the-air (OTA) client upgrades
and security patches to NantHealth HBox devices
- Deliver powerful enterprise
functionality for larger health systems, including support for
networks that exist across time zones, role-based access
limitations for larger support teams, and remote management of
NantHealth HBox devices from the DeviceConX console
“The need for interoperability in health care technology has
reached an all-time high. We see it at the health IT conferences we
attend and in the ongoing dialogue we have with our customers,”
explains Wes Madden, BSN, RN, Vice President of Connected Care,
NantHealth. “We are excited about the innovative enhancements we’ve
made to DeviceConX version 5.15 and look forward to having our
European customers experience a more streamlined workflow while
reducing costly medical errors.”
About NantHealth
NantHealth, a member of the NantWorks ecosystem of companies,
provides leading solutions across the continuum of care for
physicians, payers, patients and biopharmaceutical organizations.
NantHealth enables the use of cutting-edge data and technology
towards the goal of empowering clinical decision support and
improving patient outcomes. NantHealth’s comprehensive product
portfolio combines the latest technology in molecular analysis (GPS
Cancer® and Liquid GPS®), payer/provider platforms that exchange
information in near-real time (NaviNet and Eviti), and connected
care solutions that deliver Medical Device Interoperability (MDI).
NantHealth’s GPS Cancer® molecular profiling provides comprehensive
DNA & RNA tumor-normal profiling combined with pharmacogenomics
analysis. Liquid GPS® provides non-invasive testing of cfDNA and
cfRNA to monitor cancer mutations and potentially select targeted
therapies, chemotherapies, and immunotherapies. For more
information, please visit www.nanthealth.com and follow us on
Twitter, Facebook and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190521005690/en/
MEDIA CONTACTNANTJen
HodsonJen@nant.com562-397-3639
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Mar 2024 to Apr 2024
NantHealth (NASDAQ:NH)
Historical Stock Chart
From Apr 2023 to Apr 2024